Charles Morgan Jr Kendrick Net Worth

The estimated Net Worth of Charles Morgan Jr Kendrick is at least $10.1 Milión dollars as of 9 June 2022. Charles Kendrick owns over 6,328 units of Anthem Inc stock worth over $10,065,171 and over the last 3 years Charles sold ANTM stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Charles Kendrick ANTM stock SEC Form 4 insiders trading

Charles has made over 1 trades of the Anthem Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Charles exercised 6,328 units of ANTM stock worth $1,806,771 on 9 June 2022.

The largest trade Charles's ever made was exercising 6,328 units of Anthem Inc stock on 9 June 2022 worth over $1,806,771. On average, Charles trades about 2,109 units every 0 days since 2021. As of 9 June 2022 Charles still owns at least 20,857 units of Anthem Inc stock.

You can see the complete history of Charles Kendrick stock trades at the bottom of the page.

What's Charles Kendrick's mailing address?

Charles's mailing address filed with the SEC is 220, Virginia Avenue, Indianapolis, Marion, Indiana, 46204, United States.

Insiders trading at Anthem Inc

Over the last 10 years, insiders at Anthem Inc have traded over $153,319,533 worth of Anthem Inc stock and bought 10,600 units worth $3,007,039 . The most active insiders traders include Antonio F Neri, Ryan M. Schneider a Lewis Iii Hay. On average, Anthem Inc executives and independent directors trade stock every 21 days with the average trade being worth of $5,250,953. The most recent stock trade was executed by Charles Morgan Jr Kendrick on 9 June 2022, trading 6,328 units of ANTM stock currently worth $1,806,771.

What does Anthem Inc do?

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately 43 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner.

Complete history of Charles Kendrick stock trades at Anthem Inc

Anthem Inc executives and stock owners

Anthem Inc executives and other stock owners filed with the SEC include:

• Gail Boudreaux,
  President, Chief Executive Officer, Director
• Felicia Norwood,
  Executive Vice President, President - Government Business Division
• Gloria McCarthy,
  Executive Vice President, Chief Administrative Officer
• Gail Koziara Boudreaux,
  Pres, CEO & Director
• John Gallina,
  Chief Financial Officer, Executive Vice President
• Peter Haytaian,
  Executive Vice President, President of Commercial and Specialty Business Division
• Thomas Zielinski,
  Executive Vice President, General Counsel
• John Edward Gallina,
  Exec. VP & CFO
• Gloria Marie McCarthy,
  Exec. VP and Chief Admin. Officer
• Peter David Haytaian Esq.,
  Exec. VP and Pres of Diversified Bus. & IngenioRx
• Felicia Farr Norwood,
  Exec. VP & Pres of Gov. Bus. Division
• Elizabeth Tallett,
  Independent Chairman of the Board
• Ramiro Peru,
  Independent Director
• Julie Hill,
  Independent Director
• Robert Dixon,
  Independent Director
• Lewis Hay,
  Independent Director
• R. Kerry Clark,
  Independent Director
• Antonio Neri,
  Independent Director
• Bahija Jallal,
  Independent Director
• Ryan Schneider,
  Independent Director
• Chris Rigg,
  Vice President Investor Relations
• Ronald Penczek,
  Senior Vice President, Chief Accounting Officer, Controller
• Prakash Patel,
  Executive Vice President, President - Diversified Business Group
• Leah Stark,
  Chief Human Resource Officer, Executive Vice President
• Stephen Vartan Tanal C.F.A.,
  VP of Investor Relations
• Thomas H. Miller,
  Sr. VP & Chief Information Officer
• Anil Bhatt,
  Chief Technology Officer
• Ronald William Penczek,
  Sr. VP, Controller & Chief Accounting Officer
• Scott Wayne Anglin,
  SVP, Treasurer & Chief Investment Officer
• Joseph Swedish,
  President & CEO
• William J Ryan,
  Director
• George A Jr Schaefer,
  Director
• Jose D. Tomas,
  EVP & Chief HR Officer
• Jacquelyn H Wolf,
  EVP & Chief HR Officer
• Craig E Samitt,
  EVP & Chief Clinical Officer
• Wayne S De Veydt,
  EVP & Chief Financial Officer
• Brian T Griffin,
  EVP & President, CSBD
• Samuel R Md Nussbaum,
  EVP & Chief Medical Officer
• Martin B Silverstein,
  EVP & Chief Strategy Officer
• Kenneth R Goulet,
  EVP, Commercial & Specialty
• Blair Williams Todt,
  EVP and Chief Legal Officer
• Jeffrey D. Alter,
  EVP, IngenioRx & Anthem Health
• Susan D. De Vore,
  Director
• Charles Morgan Jr Kendrick,
  EVP & President, Commercial